Skip to main content

Table 2 Thoracic lymphadenopathies on MDCT characteristics at initial assessment

From: Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomography

Characteristics

Total

(N = 23)

Total number of thoracic LAP

79

Per patient in median (IQR) (max–min)

3 (2–5) (1–8)

 1 (%)

5 (21.7)

 2 (%)

4 (17.4)

 3 (%)

3 (13.0)

 4 (%)

5 (21.7)

 5 (%)

2 (8.7)

 6 (%)

2 (8.7)

 7 (%)

1 (4.4)

 8 (%)

1 (4.4)

Thoracic LAP > 2 (%)

14 (60.9)

Size in mean ± SD (max – min)

11.7 ± 1.7 (10–18)

Localization*

 

 1R (%)

1 (1.3)

 1L (%)

1 (1.3)

 2R (%)

3 (3.8)

 2L (%)

1 (1.3)

 3 (%)

1 (1.3)

 4R (%)

18 (22.7)

 4L (%)

3 (3.8)

 5 (%)

4 (5.0)

 6 (%)

4 (5.0)

 7 (%)

12 (15.2)

 8 (%)

2 (2.5)

 9 (%)

0 (0)

 10R (%)

16 (20.3)

 10L (%)

13 (16.5)

Calcification (%)

6 (12.5)

  1. LAP = lymphadenopathie; CT = computed-tomodensitometry
  2. *Localization according to the chest cartography of the American Thoracic Society (20)